ITU512

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ITU512, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease [Phase 1, Phase 2]